Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutationsLu Yao, Yuntao Xie, Jie Sun et al.|Breast Cancer Research and Treatment|2016Cited by 39
Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in ChinaWei Cao, Tao Ouyang, Yuntao Xie et al.|Breast Cancer Research and Treatment|2019Cited by 26
Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical TrialGuoshuang Shen, Jiuda Zhao, Yongzhi Chen et al.|Journal of Clinical Oncology|2024Cited by 22
Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancerXinguang Wang, Zhaoqing Fan, Yingjian He et al.|Supportive Care in Cancer|2019Cited by 10
Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumabLize Wang, Tao Ouyang, Yang Zhang et al.|npj Breast Cancer|2021Cited by 5